Guillain-Barre Syndrome
Showing 1 - 25 of >10,000
Prognosis in Patients With Guillain-Barre Syndrome
Recruiting
- Guillain-Barre Syndrome
-
Wenzhou, Zhejiang, ChinaFirst Affiliated Hospital of Wenzhou Medical University
Sep 11, 2023
Guillain-Barre Syndrome Trial in Wenzhou (Intravenous Immunoglobulins, Human, Methylprednisolone 500 MG Injection)
Recruiting
- Guillain-Barre Syndrome
- Intravenous Immunoglobulins, Human
- Methylprednisolone 500 MG Injection
-
Wenzhou, Zhejiang, ChinaFirst Affiliated Hospital of Wenzhou Medical University
Sep 11, 2023
Guillain-Barre Syndrome Trial (Efgartigimod Alfa-Fcab, Intravenous Immunoglobulin (IVIg))
Not yet recruiting
- Guillain-Barre Syndrome
- Efgartigimod Alfa-Fcab
- Intravenous Immunoglobulin (IVIg)
- (no location specified)
Jan 17, 2023
RWE-based Treatment Patterns and Outcomes in CIDP
Not yet recruiting
- Chronic Inflammatory Demyelinating Polyneuropathy
- +2 more
- No intervention. Retrospective observation only.
-
Salford, United KingdomNorthern Care Alliance NHS Foundation Trust
Jul 7, 2023
Guillain-Barre Syndrome Trial in Zhengzhou (immunosorbent column, intravenous immunoglobulin)
Not yet recruiting
- Guillain-Barre Syndrome
- immunosorbent column
- intravenous immunoglobulin
-
Zhengzhou, Henan, ChinaFirst Affiliated Hospital of Zhengzhou University
Oct 6, 2022
Guillain-Barre Syndrome Trial in Durham (Peripheral nerve ultrasound, Measurement of strength)
Enrolling by invitation
- Guillain-Barre Syndrome
- Peripheral nerve ultrasound
- Measurement of strength
-
Durham, North CarolinaDuke University Hospital
Sep 20, 2022
Guillain-Barre Syndrome Trial in Lahore (Proprioceptive Neuromuscular Training, Conventional Physical Therapy)
Recruiting
- Guillain-Barre Syndrome
- Proprioceptive Neuromuscular Training
- Conventional Physical Therapy
-
Lahore, Punjab, Pakistanpsrd (pakistan Society for the rehabilitation of the disabled)
Aug 4, 2022
Prognostic Factors of Gullian Barrie Syndrome Outcome
Completed
- Guillain-Barre Syndrome
- plasmapheresis
-
Assuit, Assiut, EgyptAssiut university
Dec 7, 2022
Guillain-Barré Syndrome Trial (CK0801)
Withdrawn
- Guillain-Barré Syndrome
- CK0801
- (no location specified)
Jan 3, 2023
Guillain-Barré Syndrome Trial in Vila Nova de Gaia (Inpatient Rehabilitation, Inspiratory muscle training)
Not yet recruiting
- Guillain-Barré Syndrome
- Inpatient Rehabilitation
- Inspiratory muscle training
-
Vila Nova de Gaia, PortugalCentro de Reabilitação do Norte
Jul 15, 2022
Guillain Barré Syndrome
Recruiting
- Guillain-Barre Syndrome (GBS)
- data collection
-
Basel, SwitzerlandClinic for Intensive Care Medicine; University Hospital Basel
May 4, 2022
Guillain-Barre Syndrome, Myasthenia Gravis Trial in Mansoura (diaphragmatic ultrasound)
Completed
- Guillain-Barre Syndrome
- Myasthenia Gravis
- diaphragmatic ultrasound
-
Mansoura, Not In US Or Canada, EgyptMansoura University Hospitals
May 13, 2022
Intravenous Gamma Globulin on Guillain-Barre Syndrome
Recruiting
- Guillain-barre Syndrome
-
Fuzhou, Fujian, ChinaDepartment of Neurology,First Affiliated Hospital of Fujian Medi
Jan 18, 2022
Guillain-Barre Syndrome Trial in Assiut (plasmapheresis device, Intravenous immunoglobulin)
Completed
- Guillain-Barre Syndrome
- plasmapheresis device
- Intravenous immunoglobulin
-
Assiut, EgyptAssiut university
Oct 27, 2022
Ultrasonography and Electrophysiology in GBS
Not yet recruiting
- Guillain-Barre Syndrome
- nerve ultrasonography
- (no location specified)
Jun 5, 2022
Genomics and COVID-19 Vaccine Adverse Events
Recruiting
- Vaccine Adverse Reaction
- COVID-19 vaccines
-
Vancouver, British Columbia, CanadaBritish Columbia Children's Hospital Research Institute
Jun 24, 2022
Accessible Beauty for Individuals With Upper Extremity Deficits
Not yet recruiting
- Stroke, Ischemic
- +13 more
- Use of Rare Beauty makeup products
-
Pomona, CaliforniaCasa Colina Hospital and Centers for Healthcare
Jul 12, 2023
Guillain-Barré Syndrome (GBS) Trial in France, Netherlands, United Kingdom (Imlifidase)
Recruiting
- Guillain-Barré Syndrome (GBS)
-
Le Kremlin-Bicêtre, Paris, France
- +9 more
Mar 31, 2022
Guillain-Barre Syndrome Trial in Japan (Eculizumab, Placebo)
Completed
- Guillain-Barre Syndrome
- Eculizumab
- Placebo
-
Bunkyo-ku, Japan
- +25 more
Aug 26, 2022
Immunoadsorption Versus Plasma Exchange for Treatment of
Recruiting
- GBS
- Immunoadsorption
- Plasma Exchange
-
Ulm, Baden-Württemberg, GermanyDepartment of Neurology, University of Ulm
Sep 28, 2021
An Assistive Powered Wheelchair: Stage 2 Trial
Completed
- Multiple Sclerosis
- +5 more
- Powered Wheelchair Obstacle Alerting System
-
Canterbury, Kent, United KingdomEast Kent Hospitals NHS Foundation Trust
Jul 28, 2022
Guillain-Barré Syndrome Trial in Dhaka, Aarhus (ANX005, Intravenous immunoglobulin)
Completed
- Guillain-Barré Syndrome
- ANX005
- Intravenous immunoglobulin
-
Dhaka, Bangladesh
- +1 more
Aug 9, 2021
Myasthenia Gravis, Guillain-Barre Syndrome, Multiple Sclerosis Trial in Lebanon (Current standard discharge educational
Completed
- Myasthenia Gravis
- +10 more
- Current standard discharge educational intervention
- Personalized discharge educational intervention
-
Lebanon, New HampshireDartmouth- Hitchcock Medical Center
Jan 6, 2022
National Vaccine Adverse Event Reporting Survey and Etiology
Recruiting
- COVID-19
- +12 more
- vaccinated
-
Northglenn, ColoradoNeuroganics LLC
Mar 3, 2022